Communiqué de la société OXURION du 18/03/2025 - Oxurion signs a letter of intent for the planned acquisition of a biometrics-focused CRO ...
CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces the signing of a letter of intent (LOI) for the ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果